it depends if they have news or not , and if they have someone funding it into the next step which is taking the Biomedix PADnet device , and getting their diagnostics for their 3rd Clinical Trial of Liprostin finished @ a Diabetes Relief Location. FDA approval is the next step after that for marketing Liprostin . This is what all of the most recent PRs point to - a cohesion. If it doesn't happen - it's on the company.